Jaa Roberson
Human Resources Officer bei DAY ONE BIOPHARMACEUTICALS, INC.
Profil
Jaa Roberson is currently the Chief People Officer at Day One Biopharmaceuticals, Inc. Prior to this, she worked as the Head of Human Resources at Achaogen, Inc. and as the Vice President of Human Resources at Bellicum Pharmaceuticals, Inc. from 2018 to 2020.
Ms. Roberson has an undergraduate degree from Rice University and a graduate degree from the San Francisco Conservatory of Music.
Aktive Positionen von Jaa Roberson
| Unternehmen | Position | Beginn |
|---|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Human Resources Officer | 13.09.2021 |
Ehemalige bekannte Positionen von Jaa Roberson
| Unternehmen | Position | Ende |
|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Human Resources Officer | 01.11.2020 |
| ACHAOGEN | Human Resources Officer | - |
Ausbildung von Jaa Roberson
| Rice University | Undergraduate Degree |
| San Francisco Conservatory of Music | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
